Key considerations that both clinicians and survivors face when using cannabis to relieve pain and other symptoms.
For many people, treatment cures Hodgkin lymphoma. Finishing treatment can be both stressful and exciting. You may be relieved, but you might also find it hard not to worry about the lymphoma coming back. No matter what your situation is, there are steps you can take to live well, both physically and emotionally.
A new article from Medscape examines how many cancer survivors face health challenges similar to “accelerated aging” – including early heart disease, frailty, and other conditions. If you’re a survivor, consider sharing this article with your primary care doctor. It’s a powerful way to help them understand what survivorship really means.
Hodgkin’s International recognizes that choosing to have a vaccine or forgoing one is ultimately a personal decision. In this article, Blood Cancer United (formerly Leukemia and Lymphoma Society) lists all of the vaccines that are recommended for survivors, and those that are NOT recommended.
Survivorship follow-up care is currently a much debated topic. Questions such as, “Who is in charge of my care now that treatment is completed?” are commonly asked by survivors, and the answers are varied and often confusing. This article addresses many of those questions. It includes comments from Dr. Kevin Oeffinger, who has worked tirelessly to create quality care for survivors.
Childhood cancer survivors face accelerated aging, with studies showing they develop serious health conditions nearly 18 years earlier than the general population. Even without radiation therapy, survivors remain at higher risk for secondary cancers and cardiovascular disease, underscoring the lasting impact of chemotherapy and other treatments. While survival rates have improved and new guidelines, care tools, and therapies are helping, long-term risks persist, making lifelong follow-up and protective strategies essential.
Hodgkin International’s Rachel Gingold reflects on 36 years of survivorship.
Protect yourself from COVID-19 and flu this fall and winter. Everything you need to know about new flu shots and the updated 2025-26 COVID-19 vaccine.
A major new study from the Childhood Cancer Survivor Study shows that AYA (Adolescent and Young Adult) cancer survivors continue to face excess health risks well into their 50s and beyond. Even decades after treatment, conditions like heart disease, frailty, and other chronic illnesses remain more common among survivors than in the general population. This is especially important for Hodgkin lymphoma survivors who were treated as teens or young adults and may not have regular follow-up care today.
For survivors who have finished treatment and are in remission, the question “Am I cured?” is both natural and complicated. In this thoughtful patient handout, Dr. Wendy Harpham explores how the word “cure” is used in oncology, why some doctors avoid it, and what survivors truly need to focus on after treatment.